Knights of Columbus Asset Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
1,091
+297
+37% +$303K 0.07% 258
2026
Q1
$730K Buy
794
+178
+29% +$180K 0.04% 287
2025
Q4
$662K Buy
616
+227
+58% +$217K 0.04% 284
2025
Q3
$297K Sell
389
-463
-54% -$345K 0.02% 312
2025
Q2
$664K Sell
852
-18
-2% -$14K 0.04% 269
2025
Q1
$719K Sell
870
-137
-14% -$114K 0.05% 247
2024
Q4
$777K Sell
1,007
-80
-7% -$66.2K 0.05% 250
2024
Q3
$963K Buy
1,087
+132
+14% +$119K 0.06% 242
2024
Q2
$865K Sell
955
-18
-2% -$14.4K 0.06% 266
2024
Q1
$757K Sell
973
-288
-23% -$205K 0.05% 254
2023
Q4
$735K Sell
1,261
-433
-26% -$253K 0.05% 266
2023
Q3
$910K Buy
1,694
+37
+2% +$19.1K 0.08% 242
2023
Q2
$777K Sell
1,657
-155
-9% -$65K 0.07% 255
2023
Q1
$622K Sell
1,812
-39,380
-96% -$13.3M 0.06% 256
2022
Q4
$15.1M Sell
41,192
-2,001
-5% -$709K 1.56% 5
2022
Q3
$14M Sell
43,193
-581
-1% -$184K 1.42% 10
2022
Q2
$14.2M Buy
43,774
+39,474
+918% +$11.8M 1.42% 7
2022
Q1
$1.23M Buy
4,300
+71
+2% +$18.3K 0.11% 223
2021
Q4
$1.17M Buy
4,229
+1,032
+32% +$262K 0.09% 226
2021
Q3
$739K Buy
3,197
+1,040
+48% +$257K 0.07% 236
2021
Q2
$495K Sell
2,157
-21,648
-91% -$4.35M 0.05% 243
2021
Q1
$4.45M Sell
23,805
-12,600
-35% -$2.46M 0.44% 80
2020
Q4
$6.15M Buy
36,405
+1,319
+4% +$197K 0.65% 23
2020
Q3
$5.19M Sell
35,086
-8,409
-19% -$1.3M 0.64% 34
2020
Q2
$7.14M Buy
43,495
+10,590
+32% +$1.63M 0.88% 15
2020
Q1
$4.57M Buy
32,905
+21,475
+188% +$2.95M 0.58% 37
2019
Q4
$1.5M Buy
11,430
+3,594
+46% +$417K 0.13% 267
2019
Q3
$876K Buy
+7,836
New +$872K 0.33% 89

Other funds holding LLY

Knights of Columbus Asset Advisors's LLY Position: Q2 2026 in Review

Knights of Columbus Asset Advisors increased its Eli Lilly (LLY) stake by 37% in Q2 2026, buying an estimated $303K and bringing the position to 1,091 shares worth $1.31M. The position accounts for 0.07% of the portfolio, ranked #258.

Knights of Columbus Asset Advisors first reported a position in LLY in Q3 2019 and has held it in 28 quarters since. The position peaked at $15.1M in Q4 2022. 2,876 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Knights of Columbus Asset Advisors held 1,091 shares of Eli Lilly worth $1.31M as of Q2 2026.
  • Knights of Columbus Asset Advisors bought 297 Eli Lilly shares in Q2 2026, an estimated $303K.
  • Eli Lilly made up 0.07% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #258 holding.
  • Knights of Columbus Asset Advisors first reported a position in Eli Lilly in Q3 2019 and has held it in 28 quarters since.
  • Knights of Columbus Asset Advisors's Eli Lilly position peaked at $15.1M in Q4 2022.
  • 2,876 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.